the General Program of National Natural Science Foundation of China(31301135);the Natural Science Foundation of Henan Province(162300410211);the Henan Medical Science and Technology Development Program(201203068)
Jingjing ZHANG, Ruifang HUA, Yinghua JI, et al. Long non-coding RNA CCAT2 promotes proliferation of non-small cell lung cancer cells by inhibiting transforming growth factor-β pathway[J]. Journal of Third Military Medical University, 2018, 40(2): 122-129.
DOI:
Jingjing ZHANG, Ruifang HUA, Yinghua JI, et al. Long non-coding RNA CCAT2 promotes proliferation of non-small cell lung cancer cells by inhibiting transforming growth factor-β pathway[J]. Journal of Third Military Medical University, 2018, 40(2): 122-129. DOI: 10.16016/j.1000-5404.201708038.
Long non-coding RNA CCAT2 promotes proliferation of non-small cell lung cancer cells by inhibiting transforming growth factor-β pathway
摘要
目的
2
通过体内体外实验探讨结肠癌相关转录本2(colon cancer-associated transcript 2,CCAT2)对非小细胞肺癌(non-small cell lung cancer
To explore the role of long non-coding RNA (lncRNA) colon cancer-associated transcript 2 (CCAT2) in regulating the proliferation of non-small cell lung cancer (NSCLC) cells.
Methods
2
The expression of CCAT2 in NSCLC cell lines A549 and H1299 was silenced by transfecting the cells with a short hairpin RNA (shRNA) targeting CCAT2. CCAT2 expression in the transfected cells was detected with quantitative real-time PCR (qRT-PCR)
and the cell proliferation was analyzed with CCK-8 assay and tumor cell sphere formation assay. The expression of antigen identified by monoclonal antibody Ki-67
proliferating cell nuclear antigen (PCNA)
transforming growth factor beta (TGF-β)
Smad2 and alpha smooth muscle actin (α-SMA) in the cells were detected with Western blotting.
Results
2
NSCLC cell lines A549
H1299
H1650 and H358 expressed significantly higher levels of CCAT2 than the normal lung cell line BEAS-2B (
P
<
0.01). Compared with the control cells
A549 and H1299 cells transfected with CCAT2 shRNA showed obviously decreased expression of CCAT2 (
P
<
0.01) and significantly lowered proliferation rates (
P
<
0.01). Transfection with CCAT2 shRNA resulted in significantly lowered expression of Ki-67 and PCNA but obviously enhanced expression of TGF-β pathway related proteins TGF-β
Smad2 and α-SMA (
P
<
0.01). In mouse models bearing A549 cel
l xenografts
the tumor volume was significantly smaller in CCAT2 shRNA group than in the control group
and the expression of TGF-β
Smad2 and α-SMA in the tumor tissues were significantly higher in CCAT2 shRNA group (
P
<
0.01).
Conclusion
2
CCAT2 promotes the proliferation of NSCLC cells by inhibiting TGF-β pathway both in vitro and in vivo.
关键词
Keywords
references
TORRE L A, BRAY F, SIEGEL R L, et al .Global cancer statistics, 2012[J ] .CA Cancer J Clin, 2015, 65(2): 87-108.DOI: 10.3322/caac.21262.
FERLAY J, SOERJOMATARAM I, DIKSHIT R, et al .Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J ] .Int J Cancer, 2015, 136(5): E359-E386.DOI: 10.1002/ijc.29210.
MARTENS-UZUNOVA E S, B?TTCHER R, CROCE C M, et al .Long noncoding RNA in prostate, bladder, and kidney cancer[J ] .Eur Urol, 2014, 65(6): 1140-1151.DOI:10.1016/j.eururo.2013.12.003.
LI P F, CHEN S C, XIA T, et al .Non-coding RNAs and gastric cancer[J ] .World J Gastroenterol, 2014, 20(18): 5411-5419.DOI: 10.3748/wjg.v20.i18.5411.
LIU Y, SHARMA S, WATABE K.Roles of lncRNA in breast cancer[J].Front Biosci (Schol Ed), 2015, 7: 94-108.DOI:10.2741/s427.
LING H, SPIZZO R, ATLASI Y, et al .CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer[J ] .Genome Res, 2013, 23(9): 1446-1461.DOI: 10.1101/gr.152942.112.
WU L, JIN L, ZHANG W, et al .Roles of long non-coding RNA CCAT2 in cervical cancer cell growth and apoptosis[J ] .Med Sci Monit, 2016, 22: 875-879.DOI: 10.12659/msm.897754.
ZHOU N, SI Z, LI T, et al .Long non-coding RNA CCAT2 functions as an oncogene in hepatocellular carcinoma, regulating cellular proliferation, migration and apoptosis[J ] .Oncol Lett, 2016, 12(1): 132-138.DOI: 10.3892/ol.2016.4580.
HONG Q Y, WU G M, QIAN G S, et al .Prevention and management of lung cancer in China[J ] .Cancer, 2015, 121 (Suppl 17): 3080-3088.DOI: 10.1002/cncr.29584.
CHEN W, ZHENG R, BAADE P D, et al .Cancer statistics in China, 2015[J ] .CA Cancer J Clin, 2016, 66(2): 115-132.DOI: 10.3322/caac.21338.
YANG J, LIN J, LIU T, et al .Analysis of lncRNA expre ssion profiles in non-small cell lung cancers (NSCLC) and their clinical subtypes[J ] .Lung Cancer, 2014, 85(2): 110-115.DOI: 10.1016/j.lungcan.2014.05.011.
RICCIUTI B, MENCARONI C, PAGLIALUNGA L, et al .Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy[J ] .Med Oncol, 2016, 33(2): 18.DOI: 10.1007/s12032-016-0731-2.
SHE K, HUANG J, ZHOU H, et al .lncRNA-SNHG7 promotes the proliferation, migration and invasion and inhibits apoptosis of lung cancer cells by enhancing the FAIM2 expression[J ] .Oncol Rep, 2016, 36(5): 2673-2680.DOI: 10.3892/or.2016.5105.
YU L, FANG F, LU S, et al .lncRNA-HIT promotes cell proliferation of non-small cell lung cancer by association with E2F1[J ] .Cancer Gene Ther, 2017, 24(5): 221-226.DOI: 10.1038/cgt.2017.10.
FENG J, SUN Y, ZHANG E B, et al .A novel long noncoding RNA IRAIN regulates cell proliferation in non small cell lung cancer[J ] .Int J Clin Exp Pathol, 2015, 8(10): 12268-12275.
WU L, JIN L X, ZHANG W M, et al .Roles of long non-coding RNA CCAT2 in cervical cancer ce ll growth and apoptosis[J ] .Med Sci Monit, 2016, 22: 875-879.DOI: 10.12659/msm.897754.
HUANG S Y, QING C, HUANG Z K, et al .The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis[J ] .Diag Pathol, 2016, 11(1): 49.DOI: 10.1186/s13000-016-0499-x.
LI J, ZHUANG C, LIU Y, et al .shRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cells[J ] .Oncotarget, 2016, 7(20): 28989-28997.DOI: 10.18632/oncotarget.8259.
WANG J B, SHAO N, DING X W, et al .Crosstalk between transforming growth factor-β signaling pathway and long non-coding RNAs in cancer[J ] .Cancer Lett, 2016, 370(2): 296-301.DOI: 10.1016/j.canlet.2015.11.007.
SAITO A, NAGASE T.Hippo and TGF-β interplay in the lung field[J].Am J Physiol Lung Cell Mol Physiol, 2015, 309(8): L756-L767.DOI: 10.1152/ajplung.00238.2015.
PRINCIPE D R, DOLL J A, BAUER J, et al .TGF-β: duality of function between tumor prevention and carcinogenesis[J ] .J Natl Cancer Inst, 2014, 106(2): djt369.DOI: 10.1093/jnci/djt369.
QIN C F, ZHAO F L.Long non-coding RNA TUG1 can promote proliferation and migration of pancreatic cancer via EMT pathway[J].Eur Rev Med Pharmacol Sci, 2017, 21(10): 2377-2384.
TANG J, ZHUO H, ZHANG X, et al .A novel biomarker Linc00974 interacting with KRT19 promotes proliferation and metastasis in hepatocellular carcinoma[J ] .Cell Death Dis, 2014, 5(12): e1549.DOI: 10.1038/cddis.2014.518.
ZHAO J J, HAO S, WANG L L, et al .Long non-coding RNA ANRIL promotes the invasion and metastasis of thyroid cancer cells through TGF-β/Smad signaling pathway[J ] .Oncotarget, 2016, 7(36): 57903-57918.DOI: 10.18632/oncotarget.11087.
WU Z J, LI Y, WU Y Z, et al .Long non-coding RNA CCAT2 promotes the breast cancer growth and metastasis by regulating TGF-β signaling pathway[J ] .Eur Rev Med Pharmacol Sci, 2017, 21(4): 706-714.
SCHMIDT L H, SPIEKER T, KOSCHMIEDER S, et al .The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth[J ] .J Thorac Oncol, 2011, 6(12): 1984-1992.DOI: 10.1097/JTO.0b013e3182307eac.
SUN C, LI S, ZHANG F, et al .Long non-coding RNA NEAT1 promotes non-small cell lung cancer progression through regulation of miR-377-3p-E2F3 pathway[J ] .Oncotarget, 2016, 7(32): 51784-51814.DOI: 10.18632/oncotarget.10108.
LV J, QIU M, XIA W, et al .High expression of long non-coding RNA SBF2-AS1 promotes proliferation in non-small cell lung cancer[J ] .J Exp Clin Cancer Res, 2016, 35: 75.DOI: 10.1186/s13046-016-0352-9.
NIE F Q, SUN M, YANG J S, et al .Long noncoding RNA ANRIL promotes non-small cell lung cancer cell proliferation and inhibits apoptosis by silencing KLF2 and P21 expression[J ] .Mol Cancer Ther, 2015, 14(1): 268-277.DOI: 10.1158/1535-7163.MCT-14-0492.
GUO H, HU G W, YANG Q, et al .Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells[J ] .Oncotarget, 2016, 7(49): 81806-81814.DOI: 10.18632/oncotarget.13242.
CAI Y, HE J, ZHANG D.Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the Wnt signaling pathway[J].Onco Targets Ther, 2015, 8: 2657-2664.DOI: 10.2147/OTT.S90485.
WANG Y J, LIU J Z, LV P, et al .Long non-coding RNA CCAT2 promotes gastric cancer proliferation and invasion by regulating the E-cadherin and LATS2[J ] .Am J Cancer Res, 2016, 6(11): 2651-2660.